Shiven Akshay Arora
#603Managing Director
31
Age
10y
Exp
10y
Tenure
6/10
Risk
🎓 Bachelor of Business · Bond University
📜 CS · Bond University, Australia (CS)
🏛️ None
CompensationTBP
Personality
6
Open
6
Cons
5
Extr
5
Agre
4
Neur
Blue Jet Health
Healthcare · Mid Cap
High Growth · Founder-Centric
About
Shiven Akshay Arora is the Managing Director of Blue Jet Health, a Mid Cap company in the Healthcare sector with a market cap of ₹7K Cr. A Pragmatic leader with 10 years of experience, he is known for intuition-driven decision-making and organic builder strategy. Leading the business through post-IPO growth phases with a focus on niche chemical pharmaceutical manufacturing.
FAQ
What is Shiven Akshay Arora's leadership style?
Shiven Akshay Arora is classified as a Pragmatic leader. He is intuition-driven in decision-making, with a category creator motivation and steady-marathon pace of execution.
What is Shiven Akshay Arora's educational background?
Shiven Akshay Arora holds a Bachelor of Business from Bond University and a CS from Bond University, Australia (CS).
Who is the CEO of Blue Jet Health?
Shiven Akshay Arora is the Managing Director of Blue Jet Health. He has been with the company for 10 years and in the current role for 10 years.
Leadership DNA
ArchetypePragmatic
MotivationCategory Creator
CrisisRevenue Hunter
DecisionIntuition-Driven
GrowthOrganic Builder
PeopleRelationship Led
InnovationFast-Follower
PaceSteady-Marathon
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployerSteady Employer
BrandTechnical-Expert
FocusMarket Expansion
OrientationDeep Specialist
Leadership Evidence
“Leading the business through post-IPO growth phases with a focus on niche chemical pharmaceutical manufacturing.”
⚡ Crisis●●●○○
Blue Jet Healthcare's strategy of aggressive capacity expansion in specialized CDMO segments prioritizes capturing market share from global incumbents.
🎯 Motivation●●●○○
The firm focuses on niche, high-barrier-to-entry contrast media intermediates and high-potency APIs rather than commoditized pharma manufacturing.
👥 People●●●○○
As a promoter-led organization, the leadership maintains a tight-knit operational structure centered on family-driven decision-making and long-term institutional continuity.
📈 Growth●●●○○
The company has consistently grown by investing in its own specialized manufacturing facilities and R&D capabilities rather than through large-scale M&A.
💡 Innovation●●●●○
The company specializes in niche pharmaceutical manufacturing and complex intermediates, focusing on process chemistry and scaling existing high-potential molecules rather than basic drug discovery.
🏃 Pace●●●●○
The business operates on long-term client contracts and multi-year product development cycles typical of the CDMO sector, favoring methodical capacity expansion over rapid-fire launches.
🌱 Purpose●●●●○
As a B2B CDMO player, its institutional focus is primarily on operational efficiency, regulatory compliance, and margin expansion for its global pharmaceutical clients.
🏷️ Brand●●●●●
The company positions itself as a specialized partner in complex chemistry, emphasizing its technical capabilities in contrast-media intermediates and high-potency APIs.
🤝 Customer●●●●●
Blue Jet Health operates strictly as a specialized CDMO, providing high-barrier-to-entry intermediates and APIs to global pharmaceutical companies.
💼 Employer●●●○○
As a manufacturing-heavy organization in the specialty chemicals space, it prioritizes technical expertise and long-term operational stability over high-attrition, high-pressure corporate environments.
📋 Mandate
As a specialized CDMO player, it needs to capture global market share by scaling high-barrier manufacturing capabilities.
🏢 Culture●●●○○
High promoter holding with a strong founder-family involvement in strategic vision and business operations.
Financials
Revenue FY25₹1K Cr
PAT FY25₹305 Cr
Rev CAGR 5Y14.8%
OPM35.1%
NPM29.7%
ROE26.9%
ROCE31%
P/E21.2
Fwd P/E19.9
P/B4.9
D/E1.6
Promoter79.8%
Institutional2.2%
Mkt Cap₹7K Cr
Compensation
To Be Published
Data being verified from audited reports
